Cooley

John Forrest

Deals
3
Latest
May 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 3 deals
Deals by year
John Forrest: deals by year0320252026 YTD: 2 M&A2026 YTD: 1 Equity raisings32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals John Forrest was named on, most recent first
May 2026 Candid Therapeutics –UCBAcquisitionLegal adviser to Candid Therapeutics (target)Announced2,200.0Biotech+1UCB acquisition of Candid Therapeutics
Apr 2026 CrossBridge Bio –Eli Lilly and CompanyAcquisitionLegal adviser to CrossBridge Bio (target)Announced300.0Biotech+2Eli Lilly and Company acquisition of CrossBridge Bio
Mar 2026 Candid Therapeutics ––PlacementLegal adviser to the issuerPending505.0Biotech+1Candid Therapeutics placement

Deals where John Forrest is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.